Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_SITE |
Total number of PEPFAR supported sites providing clinical care services |
2015 |
69 |
HRH_PRE |
By Graduates: Doctors |
2015 |
208 |
HRH_PRE |
By Graduates: Midwives |
2015 |
221 |
HRH_PRE |
By Graduates: Nurses |
2015 |
279 |
HRH_PRE |
By Graduates: Other |
2015 |
74 |
HRH_PRE |
Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre |
2015 |
954 |
HRH_PRE |
Sum of Graduates disaggregates |
2015 |
782 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
19,200 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
16,800 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
100,800 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
103,200 |
HTS_TST |
By Test Result: Negative |
2015 |
236,880 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
240,000 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
36,000 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
204,000 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
240,000 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
240,000 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
3,120 |
LAB_CAP |
By site support type: Direct Service Delivery (DSD) |
2015 |
69 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
69 |
LAB_CAP |
Sum of Site Support Type disaggregates |
2015 |
69 |
PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
600 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
688 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
630 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
210 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
420 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
630 |
PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
600 |
PMTCT_EID |
Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) |
2015 |
688 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2015 |
482 |
PMTCT_STAT |
By: Known positives at entry |
2015 |
494 |
PMTCT_STAT |
By: Number of new positives identified |
2015 |
194 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
34,496 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
31,149 |
PMTCT_STAT |
Sum of Positives Status disaggregates |
2015 |
688 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
69 |
SITE_SUPP |
By program area/support type: Food and Nutrition Technical Assistance-only (TA) |
2015 |
69 |
SITE_SUPP |
By program area/support type: HTC Technical Assistance-only (TA) |
2015 |
69 |
SITE_SUPP |
By program area/support type: Lab Direct Service Delivery (DSD) |
2015 |
69 |
SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
69 |
SITE_SUPP |
By program area/support type: TB/HIV Technical Assistance-only (TA) |
2015 |
69 |
SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
69 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
69 |
TX_CURR |
Age/Sex: <1 Female |
2015 |
39 |
TX_CURR |
Age/Sex: <1 Male |
2015 |
42 |
TX_CURR |
Age/Sex: 1-4 Female |
2015 |
120 |
TX_CURR |
Age/Sex: 1-4 Male |
2015 |
124 |
TX_CURR |
Age/Sex: 15+ Female |
2015 |
8,576 |
TX_CURR |
Age/Sex: 15+ Male |
2015 |
5,483 |
TX_CURR |
Age/Sex: 5-14 Female |
2015 |
395 |
TX_CURR |
Age/Sex: 5-14 Male |
2015 |
441 |
TX_CURR |
Aggregated Age/Sex: <1 Female |
2015 |
39 |
TX_CURR |
Aggregated Age/Sex: <1 Male |
2015 |
42 |
TX_CURR |
Aggregated Age/Sex: <15 Female |
2015 |
554 |
TX_CURR |
Aggregated Age/Sex: <15 Male |
2015 |
607 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
8,576 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
5,483 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
15,220 |
TX_CURR |
Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] |
2015 |
8 |
TX_CURR |
Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] |
2015 |
60 |
TX_CURR |
Sum of age/sex disaggregates |
2015 |
1,161 |
TX_CURR |
Sum of Aggregated Age/Sex <15 |
2015 |
1,161 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
14,059 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
15,220 |
TX_NEW |
Aggregated Grouping by Age: <1 Male |
2015 |
15 |
TX_NEW |
Aggregated Grouping by Age/Sex: <1 Female |
2015 |
13 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2015 |
159 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2015 |
235 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
1,921 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
1,227 |
TX_NEW |
By Age/Sex: <1 Female |
2015 |
13 |
TX_NEW |
By Age/Sex: <1 Male |
2015 |
15 |
TX_NEW |
By Age/Sex: 1-4 Female |
2015 |
37 |
TX_NEW |
By Age/Sex: 1-4 Male |
2015 |
46 |
TX_NEW |
By Age/Sex: 10-14 Female |
2015 |
49 |
TX_NEW |
By Age/Sex: 10-14 Male |
2015 |
100 |
TX_NEW |
By Age/Sex: 15-19 Female |
2015 |
217 |
TX_NEW |
By Age/Sex: 15-19 Male |
2015 |
53 |
TX_NEW |
By Age/Sex: 20-24 Female |
2015 |
441 |
TX_NEW |
By Age/Sex: 20-24 Male |
2015 |
111 |
TX_NEW |
By Age/Sex: 25-49 Female |
2015 |
1,178 |
TX_NEW |
By Age/Sex: 25-49 Male |
2015 |
980 |
TX_NEW |
By Age/Sex: 5-9 Female |
2015 |
60 |
TX_NEW |
By Age/Sex: 5-9 Male |
2015 |
74 |
TX_NEW |
By Age/Sex: 50+ Female |
2015 |
85 |
TX_NEW |
By Age/Sex: 50+ Male |
2015 |
83 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
3,542 |
TX_NEW |
Pregnancy status |
2015 |
420 |
TX_NEW |
Sum of Age/Sex disaggregates |
2015 |
3,542 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
3,542 |
TX_SITE |
Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation |
2015 |
42 |
TX_SITE |
Total number of PEPFAR-supported ART sites |
2015 |
69 |
VMMC_AE |
Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) |
2015 |
50 |
VMMC_CIRC |
By Age: 10-14 |
2015 |
3,500 |
VMMC_CIRC |
By Age: 15-19 |
2015 |
3,000 |
VMMC_CIRC |
By Age: 20-24 |
2015 |
2,200 |
VMMC_CIRC |
By Age: 25-49 |
2015 |
1,200 |
VMMC_CIRC |
By Age: 50+ |
2015 |
100 |
VMMC_CIRC |
By circumcision technique: Surgical VMMC |
2015 |
10,000 |
VMMC_CIRC |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2015 |
10,000 |
VMMC_CIRC |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2015 |
1,000 |
VMMC_CIRC |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2015 |
8,800 |
VMMC_CIRC |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2015 |
200 |
VMMC_CIRC |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2015 |
10,000 |
VMMC_CIRC |
Sum of age disaggregates |
2015 |
10,000 |
VMMC_CIRC_NGI |
By Age: 10-14 |
2015 |
3,500 |
VMMC_CIRC_NGI |
By Age: 15-19 |
2015 |
3,000 |
VMMC_CIRC_NGI |
By Age: 20-24 |
2015 |
2,200 |
VMMC_CIRC_NGI |
By Age: 25-49 |
2015 |
1,200 |
VMMC_CIRC_NGI |
By Age: 50+ |
2015 |
100 |
VMMC_CIRC_NGI |
By circumcision technique: Surgical VMMC |
2015 |
10,000 |
VMMC_CIRC_NGI |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2015 |
10,000 |
VMMC_CIRC_NGI |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2015 |
1,000 |
VMMC_CIRC_NGI |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2015 |
8,800 |
VMMC_CIRC_NGI |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2015 |
200 |
VMMC_CIRC_NGI |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2015 |
10,000 |
VMMC_CIRC_NGI |
Sum of Age disaggregates |
2015 |
10,000 |